Alterola Biotech Inc
Our plan is to use our IP and develop and market nutraceutical/functional chewing
gum and in the future medicinal chewing gum. We are ardently researching new
ways to use chewing gum as a delivery system, expanding on the kinds of applications
chewing gum has been used for in the past. We initially expected to reveal functional
chewing gum for new applications, but we were not able to do so. We will first
need to raise additional capital to develop our chewing gum for the delivery
of medicines.
We acquired intellectual property relating to certain chewing gum compositions
having appetite suppressant activity (the “IP”). Following the acquisition
of the IP, we commenced pursuing the development of chewing gums for the delivery
of nutraceutical/functional ingredients for applications such as appetite suppressant,
cholesterol suppressant, vitamin delivery, antioxidant delivery and motion sickness
suppressant.
Our mission is to improve the health and quality of life for millions of people
all over the world who are unable to or have difficulty with swallowing tablets.
As much as 40% of the adult population and an even greater percentage of the
adolescent population have difficulties swallowing pills, and we believe our
solutions will greatly benefit them.
Presently, we are focused on nutrition and health chewing gum with natural based
ingredients. The products below are currently under development and we are working
to file patents to protect the ingredients in these products.
Appetite suppressor
Cholesterol suppressor
Antioxidant gum
Motion sickness suppressor
Vitamin gum
In order to implement our business plan, however, we will need to raise funds.
We were able to secure small loans to pay the legal and accounting fees needed
to keep our reporting filings current with the Securities and Exchange Commission.
We will need more funds to meet our timetable of introducing Nutraceutical/functional
chewing gum. We expect that we will need capital of $500,000 to develop our
products.